ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Follicle Stimulating Hormone

Also written as “FSH-GEX™”, “Antioxidants + FSH” and “Follitropin Epsilon”.

Its studies are mostly in Infertility, Female · Infertility · Oligospermia, led by 3 companies.

Drug pageFollicle Stimulating Hormone: every studyAll 23 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Jan 23, 20136 company-led studies, 1 open or runningNext primary completion: Oct 15, 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Glycotope30 open or runningphase 2since Jan 23, 2013May 11, 2011none ahead
IBSA Institut Biochimiqueits history only20 open or runningphase 3since Jun 9, 2006Jun 9, 2006none ahead
Hamad Medicalits history only11 open or runningphase 4since Sep 29, 2026Sep 29, 2026Oct 15, 2027phase 4 · NCT07862725

Also a collaborator on its studies: Glycotope Biotechnology.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Glycotope only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.

  1. May 11, 2011First study: phase 1 study in Infertility, FemaleFirst studyNCT01354886 · 19 enrolled · Netherlands
  2. Nov 9, 2011Phase 1 study in Infertility, FemaleNCT01477073 · 57 enrolled · Netherlands
  3. Jan 23, 2013Phase 2 study in InfertilityNCT01794208 · 267 enrolled · Germany, Hungary
  4. Jun 9, 2016Named follicle stimulating hormoneINNProposed as its International Nonproprietary Name in WHO's List 115

TargetBeta

FSHR →read by rule
“Follicle stimulating hormone receptor agonist”ChEMBL 37, by rule

Other programs on FSHR

ProgramCompanyFurthest phaseStudies
follitropin alfaruleMerck KGaA, Darmstadt, Germanyphase 426
follitropin deltaruleFerring Pharmaceuticalsphase 318

Studies

All 3 Glycotope leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01794208Infertility · Germany, Hungary2CompletedJul 2013267
NCT01477073Infertility, Female · Netherlands1CompletedApr 201257
NCT01354886Infertility, Female · Netherlands1CompletedOct 201119

How it is read

Names in the registry

  • “FSH-GEX™”, 2 entries
  • “Follicle Stimulating Hormone”, 2 entries
  • “Antioxidants + FSH”, 1 entry
  • “Follitropin Epsilon”, 1 entry
  • “FSH (Follicle Stimulating Hormone)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.